LH
Labcorp Holdings Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+24/100
Last price
311.71
▲ 3.06 (0.99%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
308.65
Prev close
308.65
Day high
312.76
Day low
305.10
Volume
987.77K
Market cap
$25.28B
P/E (TTM)
25.53
52W range
244.52 – 341.80
Day trading desk
Gap from prior close
+0.00%
Prior close 308.65
VWAP
310.51
+0.39% from price
Relative volume
2.11×
Unusually busy
Session range
2.57%
304.92 – 312.76
Position in range
87%
Near session high
ATR (14D)
6.46
2.07% of price
Prior day high
309.79
PDH
Prior day low
305.84
PDL
Bid / ask spread
—
Quote not published
Session volume
1.55M
Avg 737.08K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+0.94%
-1.0%
1M
-4.64%
-5.8%
3M
+12.23%
+7.7%
6M
+15.80%
-2.4%
YTD
+24.25%
+10.0%
1Y
+12.56%
-3.9%
3Y
+55.04%
-27.2%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on LH open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-15.08K
Net selling
Buy transactions
3
1.92K shares
Sell transactions
8
17.00K shares
Net transactions
+11
Buys less sells
Sell : buy shares
8.9 : 1
Heavily one-sided
Insider-held shares
283.85K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 17, 26 | ANDERSON KERRII B Director |
SELL | 3.00K | $954.06K | Direct |
| Aug 11, 26 | SCHECHTER ADAM H Chief Executive Officer |
SELL | 4.67K | $1.50M | Direct |
| Aug 4, 26 | SUMMY AMY B Officer |
SELL | 924 | $283.43K | Direct |
| Aug 3, 26 | WILKINSON PETER J Officer |
SELL | 1.42K | $439.11K | Direct |
| Aug 3, 26 | WILKINSON PETER J Officer |
CONVERSION | 1.34K | $279.98K | Direct |
| Jul 2, 26 | KYLE KATHRYN W Officer |
SELL | 92 | $26.33K | Direct |
| Jul 2, 26 | VAUGHN BRYAN T Officer |
SELL | 234 | $66.97K | Direct |
| Jul 1, 26 | KYLE KATHRYN W Officer |
— | 256 | — | Direct |
| Jul 1, 26 | VAUGHN BRYAN T Officer |
— | 327 | — | Direct |
| Jun 8, 26 | KYLE KATHRYN W Officer |
SELL | 762 | $201.08K | Direct |
| May 11, 26 | SCHECHTER ADAM H Chief Executive Officer |
SELL | 5.90K | $1.50M | Direct |
| Mar 27, 26 | MELTZER JONATHAN C Officer |
SELL | 839 | $224.06K | Direct |
| Mar 27, 26 | WILKINSON PETER J Officer |
SELL | 1.63K | $436.09K | Direct |
| Mar 26, 26 | BAILEY MEGAN D Officer |
STOCK | 1.18K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANDERSON KERRII B |
Director | 6.85K | Sale |
BERBERIAN LANCE V |
Officer | 18.65K | Stock Award(Grant) |
CAVENEY BRIAN J |
Officer | 36.49K | Stock Award(Grant) |
EISENBERG GLENN A |
Officer | 37.92K | Stock Award(Grant) |
KONG GARHENG |
Director | 13.74K | Conversion of Exercise of derivative security |
NEUPERT PETER M |
Director | 13.78K | Conversion of Exercise of derivative security |
SCHECHTER ADAM H |
Chief Executive Officer | 102.56K | Sale |
SCHROEDER MARK S |
Chief Operating Officer | 12.68K | Stock Award(Grant) |
SUMMY AMY B |
Officer | 6.96K | Sale |
VAUGHN BRYAN T |
Officer | 6.75K | Sale |
Fundamentals
Market cap$25.28B
Enterprise value$31.98B
Revenue (TTM)$14.35B
Gross profit$4.14B
EBITDA$2.32B
Net income$1.00B
EPS (TTM)$12.21
Free cash flow$892.05M
Total cash$141.80M
Total debt$6.82B
Book value / share$106.39
Shares outstanding81.10M
Float80.72M
Short % of float3.03%
Dividend yield0.92%
Beta (5Y)0.85
Valuation & profitability ratios
Trailing P/E25.53
Forward P/E15.71
PEG ratio1.20
Price / sales—
Price / book2.93
EV / revenue2.23
EV / EBITDA13.78
Gross margin28.88%
Operating margin12.24%
Profit margin6.99%
Return on equity11.73%
Return on assets5.53%
Debt / equity79.12
Current ratio1.80
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $13.95B | $13.01B | $12.16B | $11.86B | +7.2% |
| Operating revenue | $13.97B | $13.07B | $12.16B | $11.86B | +6.9% |
| Cost of revenue | $9.94B | $9.38B | $8.80B | $8.15B | +5.9% |
| Gross profit | $4.01B | $3.62B | $3.36B | $3.71B | +10.7% |
| Selling, general & admin | $2.22B | $2.23B | $2.02B | $1.76B | -0.6% |
| Total operating expense | $2.50B | $2.49B | $2.24B | $1.96B | +0.4% |
| Operating income | $1.52B | $1.14B | $1.12B | $1.75B | +33.2% |
| Net interest income | -$224.10M | -$208.30M | -$199.60M | -$179.80M | -7.6% |
| Pre-tax income | $1.11B | $959.50M | $568.90M | $1.24B | +15.4% |
| Tax provision | $229.80M | $212.40M | $188.50M | $233.90M | +8.2% |
| Net income | $876.50M | $746.00M | $418.00M | $1.28B | +17.5% |
| Net income to common | $876.50M | $746.00M | $418.00M | $1.28B | +17.5% |
| Basic EPS | 10.54 | 8.89 | 4.80 | 14.05 | +18.6% |
| Diluted EPS | 10.46 | 8.84 | 4.77 | 13.97 | +18.3% |
| EBIT | $1.33B | $1.17B | $768.50M | $1.42B | +14.0% |
| EBITDA | $2.01B | $1.81B | $1.35B | $1.95B | +11.1% |
| Basic shares | 83.20M | 83.90M | 87.10M | 91.10M | -0.8% |
| Diluted shares | 83.80M | 84.40M | 87.60M | 91.60M | -0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $532.30M | $1.52B | $536.80M | $320.60M | -65.0% |
| Cash & short-term investments | $532.30M | $1.52B | $536.80M | $320.60M | -65.0% |
| Accounts receivable | $2.10B | $1.94B | $1.91B | $1.79B | +8.2% |
| Inventory | $534.70M | $493.20M | $474.60M | $470.60M | +8.4% |
| Total current assets | $4.02B | $4.81B | $3.77B | $4.63B | -16.4% |
| Property, plant & equipment | $3.08B | $3.05B | $2.91B | $2.79B | +1.2% |
| Goodwill & intangibles | $10.39B | $9.86B | $9.48B | $9.25B | +5.3% |
| Total assets | $18.39B | $18.38B | $16.73B | $20.16B | +0.1% |
| Total current liabilities | $2.82B | $3.33B | $3.23B | $3.08B | -15.2% |
| Current debt | $500.10M | $1.00B | $999.80M | $301.30M | -50.0% |
| Long-term debt | $5.08B | $5.33B | $4.05B | $5.04B | -4.6% |
| Total debt | $6.53B | $7.27B | $5.95B | $6.25B | -10.3% |
| Total liabilities | $9.76B | $10.31B | $8.83B | $10.04B | -5.4% |
| Retained earnings | $8.64B | $8.30B | $7.89B | $10.58B | +4.1% |
| Shareholder equity | $8.62B | $8.05B | $7.88B | $10.10B | +7.0% |
| Working capital | $1.20B | $1.48B | $540.20M | $1.55B | -18.9% |
| Net tangible assets | -$1.77B | -$1.81B | -$1.61B | $850.00M | +2.3% |
| Shares issued | 82.20M | 83.40M | 83.90M | 88.20M | -1.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $877.70M | $747.10M | $380.40M | $1.00B | +17.5% |
| Depreciation & amortisation | $681.10M | $643.50M | $577.30M | $537.20M | +5.8% |
| Stock-based compensation | $125.80M | $116.70M | $128.70M | $116.80M | +7.8% |
| Change in working capital | -$526.10M | -$154.10M | -$361.90M | -$376.20M | -241.4% |
| Operating cash flow | $1.64B | $1.59B | $1.33B | $1.96B | +3.4% |
| Capital expenditure | -$434.50M | -$489.90M | -$453.60M | -$429.30M | +11.3% |
| Investing cash flow | -$1.19B | -$1.37B | -$1.17B | -$1.65B | +12.6% |
| Share buybacks | -$450.00M | -$250.10M | -$1.00B | -$1.10B | -79.9% |
| Dividends paid | -$240.70M | -$243.10M | -$254.00M | -$195.20M | +1.0% |
| Financing cash flow | -$1.46B | $779.90M | -$59.30M | -$1.32B | -286.8% |
| Free cash flow | $1.21B | $1.10B | $874.10M | $1.53B | +10.0% |
| End cash position | $532.30M | $1.52B | $536.80M | $320.60M | -65.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $3.73B | $3.54B | $3.52B | $3.56B | $3.53B | +5.5% |
| Operating revenue | $3.73B | $3.54B | $3.54B | $3.56B | $3.53B | +5.5% |
| Cost of revenue | $2.62B | $2.52B | $2.52B | $2.54B | $2.48B | +3.8% |
| Gross profit | $1.11B | $1.01B | $993.20M | $1.03B | $1.05B | +9.7% |
| Selling, general & admin | $577.20M | $551.00M | $538.60M | $552.40M | $579.30M | +4.8% |
| Total operating expense | $655.30M | $626.60M | $611.20M | $621.90M | $647.60M | +4.6% |
| Operating income | $456.70M | $387.20M | $382.00M | $403.20M | $398.60M | +17.9% |
| Net interest income | -$61.10M | -$55.10M | -$55.00M | -$56.00M | -$57.10M | -10.9% |
| Pre-tax income | $386.40M | $319.70M | $190.60M | $337.00M | $304.70M | +20.9% |
| Tax provision | $87.30M | $41.70M | $25.70M | $75.50M | $66.40M | +109.4% |
| Net income | $298.70M | $277.80M | $164.70M | $261.10M | $237.90M | +7.5% |
| Net income to common | $298.70M | $277.80M | $164.70M | $261.10M | $237.90M | +7.5% |
| Basic EPS | 3.66 | 3.37 | 2.00 | 3.14 | 2.85 | +8.6% |
| Diluted EPS | 3.64 | 3.35 | 1.98 | 3.12 | 2.84 | +8.7% |
| EBIT | $447.50M | $374.80M | $245.60M | $393.00M | $361.80M | +19.4% |
| EBITDA | $626.50M | $548.10M | $418.60M | $564.00M | $532.10M | +14.3% |
| Basic shares | 81.70M | 82.30M | 82.50M | 83.10M | 83.40M | -0.7% |
| Diluted shares | 82.00M | 82.90M | 83.20M | 83.70M | 83.90M | -1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $141.80M | $981.10M | $532.30M | $598.10M | $647.30M | -85.5% |
| Cash & short-term investments | $141.80M | $981.10M | $532.30M | $598.10M | $647.30M | -85.5% |
| Accounts receivable | $2.34B | $2.29B | $2.10B | $2.11B | $2.12B | +2.4% |
| Inventory | $562.20M | $497.70M | $534.70M | $521.50M | $508.10M | +13.0% |
| Total current assets | $3.81B | $4.56B | $4.02B | $4.08B | $4.09B | -16.3% |
| Property, plant & equipment | $3.10B | $3.07B | $3.08B | $3.11B | $3.13B | +1.1% |
| Goodwill & intangibles | $10.71B | $10.59B | $10.39B | $10.25B | $10.05B | +1.1% |
| Total assets | $18.53B | $19.09B | $18.39B | $18.26B | $18.06B | -2.9% |
| Total current liabilities | $2.12B | $2.64B | $2.82B | $2.63B | $2.72B | -19.6% |
| Current debt | $900.00K | $500.40M | $500.10M | $499.90M | $499.60M | -99.8% |
| Long-term debt | $5.86B | $5.83B | $5.08B | $5.08B | $5.08B | +0.4% |
| Total debt | $6.77B | $7.24B | $6.53B | $6.53B | $6.55B | -6.6% |
| Total liabilities | $9.91B | $10.34B | $9.76B | $9.55B | $9.57B | -4.2% |
| Retained earnings | $8.70B | $8.78B | $8.64B | $8.70B | $8.50B | -0.9% |
| Shareholder equity | $8.61B | $8.73B | $8.62B | $8.70B | $8.47B | -1.4% |
| Working capital | $1.69B | $1.92B | $1.20B | $1.45B | $1.37B | -11.9% |
| Net tangible assets | -$2.10B | -$1.86B | -$1.77B | -$1.56B | -$1.57B | -12.8% |
| Shares issued | 80.90M | 82.30M | 82.20M | 83.00M | 82.90M | -1.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $299.10M | $278.00M | $164.90M | $261.50M | $238.30M | +7.6% |
| Depreciation & amortisation | $179.00M | $173.30M | $173.00M | $171.00M | $170.30M | +3.3% |
| Stock-based compensation | $34.90M | $31.70M | $29.70M | $29.20M | $34.10M | +10.1% |
| Change in working capital | -$155.20M | -$352.90M | $42.50M | -$219.10M | $95.20M | +56.0% |
| Operating cash flow | $445.50M | $191.50M | $614.20M | $387.20M | $620.60M | +132.6% |
| Capital expenditure | -$131.60M | -$121.00M | -$123.90M | -$106.70M | -$77.90M | -8.8% |
| Investing cash flow | -$366.20M | -$322.10M | -$389.90M | -$374.00M | -$94.10M | -13.7% |
| Share buybacks | -$353.80M | -$98.00M | -$225.00M | -$25.00M | -$200.00M | -261.0% |
| Dividends paid | -$58.70M | -$61.20M | -$59.30M | -$59.90M | -$59.90M | +4.1% |
| Financing cash flow | -$919.90M | $580.50M | -$290.40M | -$59.50M | -$267.40M | -258.5% |
| Free cash flow | $313.90M | $70.50M | $490.30M | $280.50M | $542.70M | +345.2% |
| End cash position | $141.80M | $981.10M | $532.30M | $598.10M | $647.30M | -85.5% |
Options analytics
Put / call volume
0.27
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
240.00
-23.0% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
55
Contracts, this expiry
Put volume
15
Contracts, this expiry
Heaviest call OI
300.00
0 contracts
Heaviest put OI
240.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 4.77 | 4.99 | +4.7% |
| Mar 2026 | 4.12 | 4.25 | +3.3% |
| Dec 2025 | 3.94 | 4.07 | +3.3% |
| Sep 2025 | 4.14 | 4.18 | +1.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 4.65 | 14 | $3.76B | +5.5% |
| Next quarter | 4.46 | 14 | $3.72B | +5.8% |
| Current year | 18.35 | 18 | $14.75B | +5.7% |
| Next year | 19.81 | 18 | $15.47B | +4.9% |
Analyst targets & ownership
Mean target$344.19
High target$385.00
Low target$293.00
Implied upside10.42%
Analyst count16
ConsensusBUY
Strong buy / Buy2 / 11
Hold4
Sell / Strong sell0 / 1
Held by insiders0.35%
Held by institutions101.82%
Institutions holding1.44K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
308.25
+1.12% from price
SMA 20
313.09
-0.44% from price
SMA 50
319.80
-2.53% from price
SMA 100
294.62
+5.80% from price
SMA 200
280.88
+10.98% from price
EMA 12
310.86
+0.27% from price
EMA 26
314.08
-0.75% from price
EMA 50
311.60
+0.03% from price
RSI (14)
47.0
Neutral
MACD (12,26,9)
-3.22
Hist -0.52
ATR (14)
6.46
2.07% of price
Realised vol 30D
22.5%
Annualised
Bollinger upper
326.18
20, 2σ
Bollinger lower
300.01
20, 2σ
50 / 200 cross
Golden
319.80 vs 280.88
Trend bias
Above 200
+10.98%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.29
Less volatile than market
Correlation to SPY
0.16
Largely independent
Realised vol 30D
22.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-15.2%
Peak to trough
Max drawdown 5Y
-35.0%
Peak to trough
ATR 14
6.46
2.07% of price
Beta (reported)
0.85
5Y monthly, from filing
Short interest
Shares short
2.45M
Prior 1.94M
Change vs prior
+26.3%
Shorts adding
% of float
3.03%
Normal
% of shares out
3.02%
Against total outstanding
Days to cover
3.5
Liquid
Float
80.72M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 21, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Sep 11, 26 | UBS | MAINTAINED | Buy | Buy |
| Sep 11, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 4, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Aug 3, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jul 31, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 31, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 13, 26 | B of A Securities | MAINTAINED | Buy | Buy |
| Jul 13, 26 | Baird | MAINTAINED | Outperform | Outperform |
| Apr 8, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Feb 24, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate$2.88 / yr
Forward yield0.92%
5-year avg yield0.96%
Payout ratio23.82%
Ex-dividend dateAug 28, 2026
Next pay dateSep 11, 2026
Last split1164:1000
Split dateJul 3, 2023
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-30
Corporate Changes & Voting Matters
8-K · 2026-09-22
Corporate Changes & Voting Matters
8-K · 2026-09-10
Corporate Changes & Voting Matters
8-K · 2026-08-28
Corporate Changes & Voting Matters
8-K · 2026-08-17
Corporate Changes & Voting Matters
8-K · 2026-08-14
Periodic Financial Reports
10-Q · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-07-30
Headlines
Evercore ISI Adjusts Price Target on Labcorp Holdings to $330 From $340, Maintains Outperform Rating
MT Newswires · 17h ago
2 Volatile Stocks to Consider Right Now and 1 We Find Risky
StockStory · 2d ago
DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace?
Zacks · 7d ago
Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026
PR Newswire · 7d ago
Is This the Right Time to Add Labcorp Stock to Your Portfolio?
Zacks · 8d ago
3 Low-Volatility Stocks That Concern Us
StockStory · 8d ago
Labcorp Holdings (LH) Eyes Acquisitions And Lab Tech Investment After 2026 Investor Day
Simply Wall St. · 14d ago
2 Small-Cap Stocks to Research Further and 1 Facing Challenges
StockStory · 14d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.